These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38860524)

  • 1. Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial.
    Liu L; Chen Q; Zhao L; Lyu T; Nie L; Miao Q; Liu Y; Zheng L; Fu F; Luo Y; Zeng C; Zhang C; Peng P; Zhang Y; Li B
    Cephalalgia; 2024 Jun; 44(6):3331024241261080. PubMed ID: 38860524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate, acupuncture, and BoNT-A for chronic migraine: a network meta-analysis.
    Zheng H; Huang SL; Chen YY; Tang TC; Qin D; Chen M
    Acta Neurol Scand; 2021 May; 143(5):558-568. PubMed ID: 33393102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acupuncture as prophylaxis for chronic migraine: a protocol for a single-blinded, double-dummy randomised controlled trial.
    Liu L; Zhao LP; Zhang CS; Zeng L; Wang K; Zhao J; Wang L; Jing X; Li B
    BMJ Open; 2018 May; 8(5):e020653. PubMed ID: 29858418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of acupuncture for migraine prophylaxis: a single-blinded, double-dummy, randomized controlled trial.
    Wang LP; Zhang XZ; Guo J; Liu HL; Zhang Y; Liu CZ; Yi JH; Wang LP; Zhao JP; Li SS
    Pain; 2011 Aug; 152(8):1864-1871. PubMed ID: 21616596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
    Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial.
    Chowdhury D; Mundra A; Datta D; Duggal A; Krishnan A; Koul A
    Cephalalgia; 2022 Aug; 42(9):859-871. PubMed ID: 35259978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
    JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT; Jaffri SF
    Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine.
    Chowdhury D; Bansal L; Duggal A; Datta D; Mundra A; Krishnan A; Koul A; Gupta A
    Cephalalgia; 2022 Apr; 42(4-5):396-408. PubMed ID: 34579560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial.
    Diener HC; Kronfeld K; Boewing G; Lungenhausen M; Maier C; Molsberger A; Tegenthoff M; Trampisch HJ; Zenz M; Meinert R;
    Lancet Neurol; 2006 Apr; 5(4):310-6. PubMed ID: 16545747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial.
    Reuter U; Ehrlich M; Gendolla A; Heinze A; Klatt J; Wen S; Hours-Zesiger P; Nickisch J; Sieder C; Hentschke C; Maier-Peuschel M
    Cephalalgia; 2022 Feb; 42(2):108-118. PubMed ID: 34743579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Long-term Effect of Acupuncture for Migraine Prophylaxis: A Randomized Clinical Trial.
    Zhao L; Chen J; Li Y; Sun X; Chang X; Zheng H; Gong B; Huang Y; Yang M; Wu X; Li X; Liang F
    JAMA Intern Med; 2017 Apr; 177(4):508-515. PubMed ID: 28241154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial.
    Yang CP; Chang MH; Liu PE; Li TC; Hsieh CL; Hwang KL; Chang HH
    Cephalalgia; 2011 Nov; 31(15):1510-21. PubMed ID: 22019576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
    Storey JR; Calder CS; Hart DE; Potter DL
    Headache; 2001; 41(10):968-75. PubMed ID: 11903524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
    Lewis D; Winner P; Saper J; Ness S; Polverejan E; Wang S; Kurland CL; Nye J; Yuen E; Eerdekens M; Ford L
    Pediatrics; 2009 Mar; 123(3):924-34. PubMed ID: 19255022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.